- Aerojet Rocketdyne Holdings Inc (NYSE:AJRD) has been upgraded to Overweight from Neutral by JPMorgan analyst Seth Seifman.
- The analyst also raised the price target to $49 from $40 (15% upside).
- Seifman mentions that the stock’s current valuation is attractive, reflecting Aerojet’s visible growth, net cash position, and the potential (eventually) to be acquired.
- According to the analyst, the ongoing proxy war between the CEO and the chairman is an unusual overhang.
- Meanwhile, Seifman noted that Aerojet is worth exploring now.
- Related: Aerojet Rocketdyne Stock Plummets As FTC Sues To Block Lockheed Martin Deal
- Price Action: AJRD shares are trading higher by 6.34% at $42.58 on the last check Thursday.
Marinus Pharmaceuticals Announces FDA Approval Of Ztalmy (ganaxolone) For CDKLDeficiency Disorder; Shares Halted On Circuit Breaker
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the U.S. Food and Drug Administration
